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Bone histology of decalcified or undecalcified samples depends on the investigation. However, in research each method provides
different information to answer the scientific question. Decalcification is the first step after sample fixation and governs what
analysis is later feasible on the sections. Besides, decalcification is favored for immunostaining and in situ hybridization. Otherwise,
sample decalcification can be damaging to bone biomaterials implants that contains calcium or strontium. On the other hand,
after decalcification mineralization cannot be assessed using histology or imaging mass spectrometry. The current study provides
a solution to the hardship caused by material presence within the bone tissue. The protocol presents a possibility of gaining
sequential and alternating decalcified and undecalcified sections from the same bone sample. In this manner, investigations using
histology, protein signaling, in situ hybridization, and mass spectrometry on the same sample can better answer the intended
research question. Indeed, decalcification of sections and grindings resulted in well-preserved sample and biomaterials integrity.
Immunostaining was comparable to that of classically decalcified samples.The study offers a novel approach that incites correlative
analysis on the same sample and reduces the number of processed samples whether clinical biopsies or experimental animals.
1. Introduction
Handling and planning of calcified tissue samples, whether
experimental animal samples or patient biopsies, is challeng-
ing.The embedding type affects the utilization of the samples
in later investigations. Therefore, the choice of embedding
technique and resin type is carefully made at the study
planning stage. In bone research, decalcified samples are
easier to handle and suitable for most common staining
procedures. However, the need of undecalcified samples to
examine mineralization or osteoid formation is crucial in
most bone diseases or their respective animal models.
Biomaterials are developing to enhance healing in dis-
eased bone, most importantly osteoporotic fractures. In the
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Figure 1: A schematic explains the experimental design and the route of samples according to the desired stain, calcification status, and
embedding medium.
last decade, more biomaterials gained interest to improve
healing outcome for delayed union and osteoporotic frac-
tures [1], among which calcium-containing materials are
arguably more than other types of materials. For example,
osteoconductive properties of injectable calcium phosphate
cements (CPC) established their ability to stimulate bone
formation [2]. Furthermore, CPCs were reported to act as
drug-delivery systems [3]. Moreover, recent developments
focused on doping CPC to enhance healing. Bisphosphonates
(i.e., risedronate) were utilized due to release kinetics prop-
erties and biocompatibility when tested on osteoblasts [4].
Zoledronate doped CPC showed increased bone density in
𝜇CT and histology in ovariectomized rats when compared to
the controls [5].
Locally, bone morphogenetic protein-2 (BMP-2) loaded
gelatinmicrospheres used to charge CPC showed stimulating
effect on osteoblasts resulting in enhanced healing in an
osteoporotic goat model [6]. Furthermore, strontium (II)
modified calcium a-tricalcium phosphate based phosphate
cement (SrCPC) was reported to enhance fracture healing in
ovariectomized rats [7–9].
In all the above-mentioned studies, histology was per-
formed on undecalcified sections or grindings. The main
limitation is the loss of possibility of staining other important
cell types such as osteocytes to reflect their response to the
materials.
This study utilized consecutive sections prepared for
either decalcified tissue testing after paraffin embedding or
undecalcified tissue investigating after PMMA embedding.
The aim of the current paper is to establish a protocol
that permits comparative analysis of same specimen to
enhance statement deduction, avoids decalcification of entire
sample, minimizes the number of experimental animals, and
increases the benefit of clinical samples from patients.
Indeed the study showed that postembedding decalcifica-
tion of sections preserved the integrity of calcium phosphate-
cement materials and enables the visualization of osteocytes,
which must be stained in decalcified tissue. Furthermore, we
could show that the method enhances information acquisi-
tion by applying interdisciplinary analysis such as imaging
mass spectrometry. Exemplarily we have chosen Time of
Flight Secondary IonMass Spectrometry (ToF-SIMS) for this
study.
2. Materials and Methods
This study was performed in full compliance with the insti-
tutional laws and the German animal protection laws. All
experiments were approved by the ethical commission of
the local governmental institution (“Regierungspraesidium
Giessen,” permit number: 89/2009 and permit number: Nr.
108/2011) and the Animal Care Committee of Thuringia
(Reg. number G 02–008/10). This study is focused on long
bones of rat animal model to show comparability. Therefore,
historical samples from several previous studies were utilized
for different analysis. Femora, both intact and with meta-
physeal defect, filled with biomaterial and tibia with coated
intramedullary pin were used. An overview of the workflow
is provided in Figure 1.
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2.1. Animal Models Grouping and Sample Collection. The first
group of samples was the intact bones that were obtained
from Sham operated female Sprague Dawley rats at the age
of 14 months. Rats were euthanized by CO
2
inhalation in
a digitally controlled cabinet using a 10-minute program
certified by the regional ethical committee. The program
included conformation of death by 50% additional time in a
euthanasia chamber filledwith 100%CO
2
. Briefly, the animals
are euthanized by 7 minutes at a 20% flow rate of CO
2
and
then maintained for an additional 3 minutes in the closed
chamber with 100% flow rate of CO
2
. After euthanasia, left
and right femora were collected for the analysis. Left femur
was embedded in PMMA (Technovit 9100 NEU, Heraeus
Kulzer, Hanau, Germany) for undecalcified staining and
postsectioning decalcification. Samples were vacuumed at
200mbar in an exicator for 15 minutes every day throughout
the 14 days of PMMA infiltration.Right femur was decalcified
in Tris-EDTA for 4–6 weeks at 4∘C for paraffin embedding
to serve as control. The experimental design and the detailed
histological and structural description were described earlier
[10].
The second group of samples was utilized from 4mm
wedge-shaped metaphyseal defect at the distal end of the
left femur as described previously [11]. The fracture gap
was filled with strontium-doped CPC (SrCPC) to enhance
healing in the osteoporotic rat fracture model. The euthana-
sia was carried out by a two-step process inhalation of
anesthesia gas (isoflurane 4% vol) followed by inhalation
of CO
2
. Confirmation of death followed with a physical
method of cervical dislocation. The CO
2
was delivered from
a compressed gas canister using a gradual fill method. A
gradual displacement rate from 10% to 30% of the chamber
volume/minutewas administeredwhichwas controlled using
a flowmeter. Finally the animal was assessed for heartbeat,
respiration, and absence of reflexes to assess the euthanasia
procedure. After euthanasia, the left femur with the defect
was collected and embedded in PMMA T9100 (Technovit
9100 NEU, Heraeus Kulzer, Hanau, Germany) for undecal-
cified staining and postsectioning decalcification. Strontium-
doped CPC contained samples were infiltrated with PMMA
without the use of vacuum to avoid a possible damage to
implant integrity at the region of sample-implant interface.
Further details were described elsewhere for defect creation
[12], material description [7], embedding procedure [10, 13],
and healing outcome [9].
The third group of samples was utilized from a study that
evaluated the effect of polyelectrolyte coatings of titanium
alloy implants on implant anchorage. The titanium alloy (Ti)
implants used here were coated with chitosan (Chi) and
hyaluronic acid (HA). Animals were euthanized at 8 weeks
after surgery using intraperitoneal injection of sodiumpento-
barbital overdose (200mg/kg, Narcoren, 16 g/100mL, Garb-
sen, Germany). Conformation of death followed through
bilateral thoracotomy. After euthanasia proximal tibiae with
the coated titanium pin were collected, then fixed in 5% neu-
tral buffered formalin for 10 days, dehydrated with increasing
concentrations of alcohol, then impregnated with a 1 : 1 mix-
ture of absolute alcohol and Technovit 7200VLC, followed by
infiltration with pure Technovit 7200VLC (Heraeus Kulzer,
Hanau, Germany), and embedded into the methacrylate-
based PMMA T7200 resin without decalcification. 200𝜇m
thick cross-sections were prepared using an EXAKT 300
diamond band saw. Next, the slices were ground with the
EXAKT 400CS grinding system and special grinding papers
to a thickness of 15–25𝜇m. A complete description of the
study and the anchorage outcome of the different coatings
was previously reported [8].
2.2. Sectioning and Grindings. Paraffin embedded decalcified
samples were sectioned in 5 𝜇m thick sections. Undecalcified
femora samples (intact and defect) embedded in PMMA
T9100were sectioned in 5 𝜇mthick sections ontoKawamoto’s
film (SECTION-LAB Co. Ltd.,Hiroshima, Japan). Undecalci-
fied rat tibia samples with coated titanium pin embedded in
PMMA T7200 were ground into 15–20 𝜇m thick grindings.
2.3. Decalcification Protocol. Sections and grindings were
deplastified in methacrylic acid (MEA) three times for 10
minutes each and then decalcified in a solution of 4% PFA
(paraformaldehyde) and EDTA. The process went 2 days
for 5 𝜇m thick sections and one week for 15–25 𝜇m thick
grindings. Staining protocols were then carried out starting
from the descending alcohol series.
2.4. Investigative Histology. The first sample group served as
a control to check validity of enzyme histochemical staining
and immunostaining.Therefore, decalcified paraffin sections,
undecalcified PMMA sections, and postembedding decal-
cified PMMA sections were used to visualize osteoclasts
by enzyme histochemical tartrate resistant acid phosphatase
(TRAP) staining as shown in [13] and immunostaining for
type I collagen (ColI) as described in [10].
Samples from the second group (metaphyseal defect filled
with SrCPC) were stained with the osteoid specific stain von
Kossa/van Gieson as described earlier [13].
Samples from the third group (proximal tibia with coated
titanium pin) were then stained with modified Masson-
Goldner without removing the PMMA as described earlier
[8].
The postembedding decalcified PMMA sections from
second and third sample groupswere stainedwith silver (50%
silver nitrate in formic acid + gelatin for 45 minutes, washing
twice with distilled water and 5% sodium thiosulfate for 10
minutes) to visualize osteocytes, protocol described in [10].
2.5. ToF-SIMS Analysis. Same section was measured in ToF-
SIMS before decalcification and then again after decalcifica-
tion and silver staining.
ToF-SIMS measurements were carried out with a ToF-
SIMSVmachine (IONTOF,Mu¨nster, Germany). Data acqui-
sition and evaluation were performed using SurfaceLab
software 6.6. The images were obtained in the “stage scan”
mode, where single measurement regions (patches) of 400
× 400𝜇m2 are stitched together to acquire images of 9 ×
6.5mm2 and 9.5 × 7.5mm2, respectively. The spectrometry
mode was applied with a mass resolution of m/z (C
2
H+
5
) =
5625 and a lateral resolution of <10mm. For these images,
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Figure 2: Specific osteoclast staining after postembedding decalcification of rat femur. Comparison of undecalcified bone sections with
decalcified bone reflects no alteration of bone integrity. (a–c) Preembedding decalcified and paraffin embedded bone samples show TRAP
positive cells. (d–f) Undecalcified PMMA section shows the specificity of TRAP staining. (g–i) Postembedding decalcification result is
comparable to both decalcified and undecalcified sections. (c, f, and i) Magnified images show the multinucleated osteoclasts on bone
surface. Images (a), (d), and (g) were acquired by 5x magnification objective; then individual tiles were stitched together by Leica application
suite (LASX) software. Images (b), (e), and (h) were acquired by 40x magnification objective. Images (c), (f), and (i) were acquired by 100x
magnification objective.
13 scans with 5 shots/pixel, 100 pixel per millimeter, and 5
frames per patch were recorded. Bi
3
+ was used as primary ion
species. A detailed description of the method can be found
elsewhere [14–16].
3. Results
The results reported here represent a systematic prove of a
protocol that, to our knowledge, was never obtained with
existing processing and embedding techniques. Postembedd-
ing section decalcification preserved sample integrity without
structural discrepancies when compared to the sections
from undecalcified specimens. Investigative stains specific to
paraffin embedded samples, such as silver staining of osteo-
cytes, obtained good results after postembedding PMMAsec-
tion decalcification. The differentiation steps in all protocols
were exactly the same for all sample groups.
The protocol used for TRAP biochemical staining was
the standard one used for paraffin embedded samples (Fig-
ures 2(a)–2(c)) and the undecalcified samples embedded
in PMMA resin (Figures 2(d)–2(f)). The overview of the
postembedding decalcified sections (Figure 2(g)) shows int-
ermediate intensity of overall staining, reflecting lower reac-
tion to the hematoxylin counterstaining compared with the
undecalcified section but higher reaction when compared
with paraffin embedded decalcified sample sections.
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Figure 3: Postembedding decalcification of rat femur preserves antigen specificity in bone tissue. (a–c) Preembedding decalcified bone
samples embedded in paraffin show positive ColI signaling in bone matrix. (d–f) PMMA undecalcified section shows the specificity of ColI
immunostaining. (g–i) Postembedding decalcification shows no discrepancies in signal intensity and localization. Images (a), (d), and (g)
were acquired by 5x magnification objective; then individual tiles were stitched together by Leica application suite (LASX) software. Images
(b), (e), and (h) were acquired by 5x magnification objective. Images (c), (f), and (i) were acquired by 10x magnification objective.
Immunostaining of ColI to investigate bone matrix
showed comparable signal intensity on pre- and postdecalci-
fied sections (Figure 3) and in comparison to paraffin embed-
ded sections.The staining proves that the antibody specificity
was not jeopardized by the postembedding decalcification.
The postembedding decalcification also maintained
integrity of SrCPC located in the metaphyseal defect at the
distal femur of osteoporotic rats (Figure 4).The undecalcified
von Kossa/van Gieson stain showed the bone in black and
nonmineralized tissue as red (Figure 4(a)).The SrCPC is also
stained when light-reduced silver is visualized as metallic
silver in black.
In this status, visualization of osteocyte and cellular
network is not feasible. However, the postembedding decalci-
fication shows clear osteocyte aggregation at the bone implant
interface with their canaliculi in silver staining (Figures
4(c)–4(d)).
The same principle was applied to the grinding where
titanium pins were coated with hyaluronic acid. Coatings
of titanium alloy implants were meant to enhance implant
anchorage. Although the modified Masson-Goldner stain
clearly recognizes various tissue types and their mineral-
ization, visualization of osteocyte and cellular network was
not feasible (Figure 5, upper panel). After decalcification,
implementation of silver stain could depict the osteocytes
and osteocytic canaliculi. The section quality and material
integrity were not affected. Visually no material loss at the
bone-material interface was observed which is crucial to
deduce information about the coating properties (Figure 5,
lower panel).
However, the interdisciplinary potential of the proposed
protocol was best demonstrated through testing by means of
ToF-SIMS.
Before decalcification, calcium ion (Ca+) distribution
within the SrCPC and the mineralized bone was apparent
(Figure 6(a)). Presentable is the strontium ion (Sr+) distri-
bution mainly within the cement and in the close vicinity
(Figure 6(b)). The collagen fiber components were also
seen in regions of bone matrix irrelevant of mineralization
(Figure 6(c)). The overlay reflects the signal intensity and
distribution of the investigated constituents (Figure 6(d)).
Interestingly, after decalcification no Ca+ or Sr+ were seen
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Figure 4: Postembedding decalcification of rat femur preserves the integrity of calcium-containing materials and allows investigating
osteocytes. The SrCPC cement in the fracture defect was embedded in PMMA T9100. (a-b) von Kossa/van Gieson staining of undecalcified
bone sample differentiates soft tissue around the fracture defect (red) and stains ossified tissue and materials in black. (c-d) Silver staining of
postembedding decalcified sections visualizes osteocytes within thematrix and differentiates the implant from the surrounding tissue. Images
(a) and (c) were acquired by 5xmagnification objective; then individual tiles were stitched together by Leica application suite (LASX) software.
Images (b) and (d) were acquired by 40x magnification objective while inset of image (d) was acquired by 100x magnification objective.
in the silver-stained section reflecting a complete decalcifi-
cation within very short time (Figure 6(e)). However, the
collagenous portion remained constant before (Figure 6(e))
and after decalcification (Figure 6(f)). Distribution of silver
ions was seen in the same areas of the collagenous portion
(Figure 6(g)). The overlay of the Ca+ signal before decalcifi-
cation andAg+ after decalcification (Figure 6(h)) reflects how
silver only stains the remaining organic compounds with the
exception of the bonematrix (Figure 6(i)). However, the light
microscopy image can still show the borders of the material
areas without distortion besides enabling the visualization of
osteocyte and cellular network in the vicinity and within the
materials (Figures 6(i)–6(j)).
4. Discussion
Theacquisition of clinical and preclinical samples depends on
limited availability. Inmany cases, the need for decalcification
in special investigative histology is hindered due to the pres-
ence of bone substitute materials. Furthermore, correlating
light microscopy from the same sample with new imaging
techniques based on element analysis such as ToF-SIMS is
demanding.
Decalcified sections from undecalcified specimens were
tested in comparison with the sections originated from
decalcified specimens; both groupswere stainedwith a hema-
toxylin eosin stain, an enzyme histochemical stain (TRAP),
and an immunostaining of ColI.
Paraffin is an inert embedding medium, which is applied
only to decalcified tissue. However, paraffin does not interact
chemically with tissue components [17]. Due to decalcifi-
cation, bone structure is poorly preserved and information
about mineralization is lost. Often, decalcified bone samples
exhibited shrinking artifacts especially in bone marrow area
after paraffin embedding. Moreover, immunolocalization of
cellular and bone matrix markers such as ColI and TRAP is
routinely performed on paraffin embedded decalcified bone
[18, 19].
Methyl-methacrylate (MMA) embedding showed depen-
dable tissue coloration [20]. However, high polymerization
temperature ofMMAaffects proteins and hinders subsequent
antibody-antigen coupling [21]. However, the effect was
improved by the introduction of low-temperature polymer-
izing PMMA (Technovit 9100 New), and immunostainings
became feasible [22, 23]. The introduction of bone substitute
materials with mineral composition created a new hardship
as preembedding decalcification will cause material loss.
Furthermore, studies compared bone structure embedded
in low-temperature polymerizing PMMA with decalcified
bone samples embedded in paraffin. Bone morphology and
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Figure 5: Histological stains of undecalcified tibia with intramedullary pin aligned in compliance with decalcified bone. The bone samples
were embedded in PMMAT7200.Masson-Goldner staining of undecalcified bone shows the presence of soft tissue around the implant region
and the magnified image shows the clear view of osteoid (a–c). The decalcified bone section shows the comparative view and presence of soft
tissue around the implant region (d–f). The magnified image shows the view of osteocyte canaliculi. Images (a) and (d) were acquired by
5x magnification objective; then individual tiles were stitched together by Leica application suite (LASX) software. Images (b) and (e) were
acquired by 40x magnification objective. Images (c) and (f) were acquired by 100x magnification objective.
structure were improved in PMMA sections and no cracking
effects were seen [24]. Moreover, decalcified bones showed
reduced immunohistochemical reaction [24]. Other studies
showed that decalcification resulted in distorted tissue mor-
phology and reduced staining quality [25].
Furthermore, the widely accepted fluorochrome labelling
is an efficient ethically acceptable standard technique to
investigate bone dynamics in skeletal research. The method
is applied clinically on iliac crest biopsies of patients in
combination with plain histology [26] and in preclinical
animal models to investigate bone formation rate [27]. The
use of fluorochrome labelling is increasing with the prompt
development of finite element methods. However, imaging of
fluorochrome labelling is only possible on undecalcified sam-
ples, which hinders further histological analysis especially
with small sample or rare pathological samples.
The proposed protocol shall enable diverse utilization
of fluorochrome labelled bone samples by using same or
sequential sections. Thereby, the presented protocol opens
more possibilities to correlate bone dynamics with cellular
and structural changes using image registry techniques or in
mathematical modelling in terms of finite element analysis.
Furthermore, the labelled areas upon postembedding decal-
cification can still be investigated in the subsequent section if
needed.
Taken together, the proposed protocol offers the advan-
tages of undecalcified bone embedding in low-temperature
polymerization PMMA. Thereby, the method preserves the
integrity of biomaterials when sample decalcification is
needed.
Furthermore, biomaterials still require characterization
on how they affect cellular behavior. The obligatory use of
a different set of animals to gain samples for rhodamine
staining to investigate osteocytes in mineral-based bioma-
terials is challenging. The difficulty of decalcification was
circumvented by the proposed protocol. More importantly,
the need of additional set of animals in fracture healing
studies with biomaterials can be avoided.
For example, the study of the second group of samples
that previously reported enhanced healing using SrCPC
compared to CPC only in osteoporotic fractures [12]. This
applies also to the study of the third group of samples that
previously reported enhanced biomechanical competence
through better implant anchorage resulting from coating of
titanium pins [8]. Unfortunately, the interesting results could
not be correlated to the role of osteocytes due to the technical
inapplicability. Such a role can now be investigated using the
current protocol with comparable material visual integrity
before and after decalcification.
ToF-SIMSmeasurement as a sensitive chemical investiga-
tion is more informative in bone tissue when performed on
undecalcified samples. However, same-sample investigation
is more powerful to understand changes in physiological
samples.
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Figure 6: Silver stain visualizes the completely decalcified biomaterial and the osteocytes. Undecalcified femur with SrCPC in PMMAT9100
sections shows the clear portions of minerals and organic compounds. (a) Ca+ distribution accounts for CPC and mineralized bone matrix.
(b) Strict presence of Sr+ within the SrCPC area and its vicinity. (c) Organic compound at the bone matrix areas and not the CPC area. (d)
Overlay of minerals (Ca+: green; Sr+: blue; and organic compound: red) serves as a map of portions distribution before decalcification. (e-f)
Collagenous portion before (e) decalcification in the same areas as after (f) decalcification. (g) The Ag+ staining corresponds to the areas of
organic compounds. (h) Overlay of Ca+ (red) before decalcification and Ag+ after decalcification (green) hints that the Ag+ is visible after
mineral removal. (i-j) Light microscopic imaging of decalcified bone section shows the comparative view of the implant and the surrounding
tissue. Furthermore, osteocytes and cell canaliculi are evident in the bone matrix. Image (i) was acquired by 5x magnification objective; then
individual tiles were stitched together by Leica application suite (LASX) software. (j) was acquired by 40x magnification objective whereas
inset was acquired by 100x magnification objective.
Interestingly, the understanding of the silver staining
ability of osteocyte canaliculi on decalcified sections was
annotated through the ToF-SIMS analysis. In undecalcified
samples, silver ions attach to the mineralized portions and
are visualized black under the microscope after reduction
by light. After the complete decalcification, silver ions stain
the remaining collagenous compounds. However, the results
suggest that this effect appearsmore clearly due to the absence
of mineralized compounds.
Furthermore,ToF-SIMSimagingprovides clear evidence of
the complete demineralization (Figure 7(a)).More importan-
tly, themeasurement and the localization of organic compou-
nds before and after decalcification show themild effect of the
decalcification protocol on thematrix structure (Figure 7(b)).
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Figure 7: Chemical investigations show preserved collagenous portion before and after decalcification. (a) Complete depletion of
mineral constituents within tissue and material. (b) Minerals masked the signal of organic compounds before decalcification; however,
after decalcification the surface analysis depicts demineralized areas as cartilaginous portions. The overlay shows that portions before
decalcification were highly preserved.
5. Conclusion
In experimental trauma surgery and orthopedics, the need of
histological evaluation is immense. Two choices are offered
for pathologists and researchers. (1) Decalcification and
paraffin embedding are suitable for immunohistochemistry
and in situ hybridization, although they can result in cracks
and inferior hard tissue integrity during sectioning. (2)Unde-
calcification is preferable for mineralized tissue, although less
combatable with immunostaining. The developing field of
material increased hardship as preembedding decalcification
leads to the partial or complete loss of the biomaterial whereas
undecalcification compromises the information acquired as
osteocyte visualization. In many cases, additional set of
animals is planned to obtain both types of information.
Clinically, several patient biopsies are then needed. Here
we propose a technique that allows the work on successive
sections with two different approaches to obtain all possible
information. Furthermore, the need of same-sample analysis
in light microscopy and chemical analysis widens our under-
standing of biological and chemical hallmarks of pathological
tissue alterations.
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